查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1266370

全球結腸鏡檢查市場：按應用（結腸癌、潰瘍性結腸炎、克羅恩病等）按最終用戶（醫院、門診手術中心等）分類：機會分析和行業預測，2021-2031 年

Colonoscope Market By Application (Colorectal Cancer, Ulcerative Colitis, Crohns Disease, Others), By End User (Hospitals, Ambulatory Surgery Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 220 Pages | 商品交期: 2-3個工作天內

價格

2021 年全球結腸鏡檢查市場價值 12 億美元，預計 2022 年至 2031 年的複合年增長率為 7.6%，到 □□2031 年達到 25 億美元。

結腸鏡是一種靈活的光纖儀器，通過肛門插入以檢查大腸。 它可用於診斷消化系統疾病，例如炎症性腸病和結腸癌。 它還有助於治療和預防結腸癌。 醫療保健提供者建議對中年和老年人進行常規結腸鏡檢查以篩查癌症。 大多數人都會進行第一次結腸鏡檢查以進行常規癌症篩查。 由於患結直腸癌的風險在統計學上隨著年齡的增長而增加，美國癌症協會建議至少在 45 歲之前進行定期篩查。 結腸鏡檢查還允許採取治療措施，例如通過儀器端口引入特殊工具以進行活組織檢查和切除癌性病變。 腸道版本的皮膚點刺試驗利用結腸鏡檢查對注入結腸粘膜的食物的局部反應，似乎具有更好的預測價值，但尚未得到廣泛應用。

結腸鏡檢查市場的增長受到結腸相關疾病發病率增加、老齡化社會對醫療服務需求增加以及結腸鏡檢查領域持續發展的推動。 此外，老年人口的增加以及為促進結腸疾病診斷而引入結腸鏡檢查系統的迅速增加預計將對市場增長做出重大貢獻。 此外，全球結腸鏡檢查市場的增長在很大程度上取決於結腸鏡檢查技術不斷進步等因素，這些因素肯定會推動市場的增長。 全球結腸鏡檢查市場的主要參與者正在通過產品發布、收購、研發投資來推進結腸鏡檢查等，以加強其市場地位並維持競爭環境，選擇不同的策略。 例如，在 2022 年，SMART Medical Systems Ltd. 宣布其基於奧林巴斯 PCF 系列結腸鏡的 G-EYE 結腸鏡獲得 FDA 額外批准，該結腸鏡也獲得了 510(k) 批准。 這將允許在美國使用三個內窺鏡品牌的常用結腸鏡：Olympus、Fujifilm 和 Pentax Medical。

對結腸鏡檢查益處的認識不斷提高、篩查的使用率不斷提高以及患有結腸相關疾病的患者人數激增是推動市場增長的一些關鍵因素。 然而，結腸鏡檢查過程中並發症的風險和設備的高成本限制了市場增長。 相反，新產品和先進產品的推出有望在預測期內改變市場動態，並為市場增長提供有利可圖的機會。 醫療設備領域的廣泛研發活動有望為市場擴張開闢新途徑，同時醫療基礎設施也將得到顯著改善。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 頂級影響因子
    • 頂級投資基金
  • 波特的五力分析
    • 供應商的議價能力
    • 買家的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭對手的實力
  • 市場動態
    • 司機
      • 結直腸癌患病率上升
      • 結腸鏡成像技術不斷進步
      • 越來越喜歡微創手術
    • 約束因素
      • 與結腸鏡檢查程序相關的高風險
    • 機會
      • 醫療機構使用結腸鏡檢查的人數激增
  • 分析 COVID-19 對市場的影響

第 4 章結腸鏡檢查市場：按應用

  • 概覽
    • 市場規模和預測
  • 結直腸癌
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析
  • 潰瘍性結腸炎
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析
  • 克羅恩病
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析
  • 其他
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析

第 5 章結腸鏡檢查市場：按最終用戶分類

  • 概覽
    • 市場規模和預測
  • 醫院
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析
  • 門診手術中心
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析
  • 其他
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析

第 6 章結腸鏡檢查市場：按地區

  • 概覽
    • 市場規模和預測：按地區
  • 北美
    • 主要趨勢和機遇
    • 市場規模和預測：按應用
    • 市場規模和預測：按最終用戶分類
    • 市場規模/預測：按國家/地區分類
      • 美國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 加拿大
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 墨西哥
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
  • 歐洲
    • 主要趨勢和機遇
    • 市場規模和預測：按應用
    • 市場規模和預測：按最終用戶分類
    • 市場規模/預測：按國家/地區分類
      • 德國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 法國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 英國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 意大利
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 西班牙
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 其他歐洲
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
  • 亞太地區
    • 主要趨勢和機遇
    • 市場規模和預測：按應用
    • 市場規模和預測：按最終用戶分類
    • 市場規模/預測：按國家/地區分類
      • 中國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 日本
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 印度
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 澳大利亞
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 韓國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 其他亞太地區
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
  • 拉美
    • 主要趨勢和機遇
    • 市場規模和預測：按應用
    • 市場規模和預測：按最終用戶分類
    • 市場規模/預測：按國家/地區分類
      • 巴西
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 沙特阿拉伯
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 南非
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • LAMEA 的其餘部分
      • 主要市場趨勢、增長動力和機遇
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類

第七章競爭格局

  • 介紹
  • 關鍵成功策略
  • 10 家主要公司的產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 定位頂級公司，2021 年

第八章公司簡介

  • Olympus Corporation
  • Stryker Corporation
  • Pentax Medical
  • Fujifilm Holdings
  • Medtronic plc
  • Boston Scientific Corporation
  • Endomed Systems
  • Sonoscape Medical Corp.
  • Ambu A/S
  • Endofresh
Product Code: A07073

The global colonoscope market was valued at $1.2 billion in 2021, and is projected to reach $2.5 billion by 2031, growing at a CAGR of 7.6% from 2022 to 2031.  

A colonoscope is a flexible fiber-optic instrument inserted through the anus to examine the colon. It is helpful for diagnosing gastrointestinal diseases, such as inflammatory bowel disease and colon cancer. It can also help treat and prevent colon cancer. Healthcare providers recommend routine colonoscopies for middle-aged and older adults to screen for cancer. Most people have their first colonoscopy for routine cancer screening. Statistically, the risk of developing colorectal cancer goes up as age increases, which is why the American Cancer Society recommends regular screening at least by the age of 45. The colonoscope also allows for therapeutic actions like a dedicated tool could be introduced through the instrument port to perform a biopsy or removal of cancerous lesions. A gut version of skin prick testing using local reactions to food injected into the colonic mucosa via the colonoscope appears to have a better predictive value but is not widely applied.  

The growth of the colonoscopes market is driven by an increase in incidence of colon related diseases, rise in demand for healthcare services for the aging population and continuous developments in the field of colonoscopy. Moreover, rise in geriatric population and surge in adoption of colonoscope systems to facilitate better diagnosis of colon diseases is expected to notably contribute toward the market growth. Furthermore, the global colonoscopes market growth is largely driven by factors such as an increase in advancements of colonoscope which is surely expected to lead the growth of the market. Prominent players in the global colonoscopes market have opted various strategies such as product launch, acquisition, and investments in R&D for advancement in colonoscopes to strengthen their position in the market and sustain the competitive environment. For instance, in 2022, SMART Medical Systems Ltd., announced an additional FDA clearance for its G-EYE Colonoscope which is based on Olympus' PCF colonoscope series which is also 510(k) cleared. With this additional FDA clearance, G-EYE is available for use in the U.S. market on the commonly used colonoscope models of all three leading endoscopy brands namely OLYMPUS, FUJIFILM, and PENTAX Medical.  

A significant increase in awareness about the advantages of colonoscope, rise in the usage of this device in the screening, and surge in the number of patients suffering from colon related diseases are some of the other key factors driving the growth of the market. However, risks of complications during the colonoscopy and high cost of the device restricts the market growth. Conversely, the introduction of new and advanced products has changed the market dynamics during the forecast period and is expected to provide lucrative opportunities for the growth of the market. Extensive R&D activities in the field of medical devices along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market.  

The global colonoscopes market is segmented on the basis of application, end user and region. On the basis of application, the market is divided into colorectal cancer, ulcerative colitis, Crohns disease and others. On the basis of end user, the market is categorized into hospitals, ambulatory surgery centers and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).  

Major companies profiled in the report include: Olympus Corporation, Stryker Corporation, FUJIFILM Holdings Corporation, Medtronic Plc, Boston Scientific Corporation, PENTAX Medical, Endomed System, Sonoscape Medical Corporation, Ambu A/S, and Endofresh. 

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the colonoscope market analysis from 2021 to 2031 to identify the prevailing colonoscope market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the colonoscope market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global colonoscope market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Application

  • Colorectal Cancer
  • Ulcerative Colitis
  • Crohns Disease
  • Others

By End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • Stryker Corporation
  • Medtronic plc
  • Pentax Medical
  • Olympus Corporation
  • Fujifilm Holdings
  • Sonoscape Medical Corp.
  • Ambu A/S
  • Endofresh
  • Boston Scientific Corporation
  • Endomed Systems

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Bargaining power of suppliers
    • 3.3.2. Bargaining power of buyers
    • 3.3.3. Threat of substitutes
    • 3.3.4. Threat of new entrants
    • 3.3.5. Intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in the prevalence of colon cancer
      • 3.4.1.2. Rise in technological advancement in colonoscope imaging
      • 3.4.1.3. Increase in preference of population towards minimally invasive techniques
    • 3.4.2. Restraints
      • 3.4.2.1. High risks involved during the colonoscopy procedures
    • 3.4.3. Opportunities
      • 3.4.3.1. Surge in usage of colonoscope in healthcare facilities applications
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: COLONOSCOPE MARKET, BY APPLICATION

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Colorectal Cancer
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Ulcerative Colitis
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Crohns Disease
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Others
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country

CHAPTER 5: COLONOSCOPE MARKET, BY END USER

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Hospitals
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Ambulatory Surgery Centers
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: COLONOSCOPE MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key trends and opportunities
    • 6.2.2. Market size and forecast, by Application
    • 6.2.3. Market size and forecast, by End User
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Key market trends, growth factors and opportunities
      • 6.2.4.1.2. Market size and forecast, by Application
      • 6.2.4.1.3. Market size and forecast, by End User
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Key market trends, growth factors and opportunities
      • 6.2.4.2.2. Market size and forecast, by Application
      • 6.2.4.2.3. Market size and forecast, by End User
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Key market trends, growth factors and opportunities
      • 6.2.4.3.2. Market size and forecast, by Application
      • 6.2.4.3.3. Market size and forecast, by End User
  • 6.3. Europe
    • 6.3.1. Key trends and opportunities
    • 6.3.2. Market size and forecast, by Application
    • 6.3.3. Market size and forecast, by End User
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. Germany
      • 6.3.4.1.1. Key market trends, growth factors and opportunities
      • 6.3.4.1.2. Market size and forecast, by Application
      • 6.3.4.1.3. Market size and forecast, by End User
      • 6.3.4.2. France
      • 6.3.4.2.1. Key market trends, growth factors and opportunities
      • 6.3.4.2.2. Market size and forecast, by Application
      • 6.3.4.2.3. Market size and forecast, by End User
      • 6.3.4.3. UK
      • 6.3.4.3.1. Key market trends, growth factors and opportunities
      • 6.3.4.3.2. Market size and forecast, by Application
      • 6.3.4.3.3. Market size and forecast, by End User
      • 6.3.4.4. Italy
      • 6.3.4.4.1. Key market trends, growth factors and opportunities
      • 6.3.4.4.2. Market size and forecast, by Application
      • 6.3.4.4.3. Market size and forecast, by End User
      • 6.3.4.5. Spain
      • 6.3.4.5.1. Key market trends, growth factors and opportunities
      • 6.3.4.5.2. Market size and forecast, by Application
      • 6.3.4.5.3. Market size and forecast, by End User
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Key market trends, growth factors and opportunities
      • 6.3.4.6.2. Market size and forecast, by Application
      • 6.3.4.6.3. Market size and forecast, by End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key trends and opportunities
    • 6.4.2. Market size and forecast, by Application
    • 6.4.3. Market size and forecast, by End User
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. China
      • 6.4.4.1.1. Key market trends, growth factors and opportunities
      • 6.4.4.1.2. Market size and forecast, by Application
      • 6.4.4.1.3. Market size and forecast, by End User
      • 6.4.4.2. Japan
      • 6.4.4.2.1. Key market trends, growth factors and opportunities
      • 6.4.4.2.2. Market size and forecast, by Application
      • 6.4.4.2.3. Market size and forecast, by End User
      • 6.4.4.3. India
      • 6.4.4.3.1. Key market trends, growth factors and opportunities
      • 6.4.4.3.2. Market size and forecast, by Application
      • 6.4.4.3.3. Market size and forecast, by End User
      • 6.4.4.4. Australia
      • 6.4.4.4.1. Key market trends, growth factors and opportunities
      • 6.4.4.4.2. Market size and forecast, by Application
      • 6.4.4.4.3. Market size and forecast, by End User
      • 6.4.4.5. South Korea
      • 6.4.4.5.1. Key market trends, growth factors and opportunities
      • 6.4.4.5.2. Market size and forecast, by Application
      • 6.4.4.5.3. Market size and forecast, by End User
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Key market trends, growth factors and opportunities
      • 6.4.4.6.2. Market size and forecast, by Application
      • 6.4.4.6.3. Market size and forecast, by End User
  • 6.5. LAMEA
    • 6.5.1. Key trends and opportunities
    • 6.5.2. Market size and forecast, by Application
    • 6.5.3. Market size and forecast, by End User
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Key market trends, growth factors and opportunities
      • 6.5.4.1.2. Market size and forecast, by Application
      • 6.5.4.1.3. Market size and forecast, by End User
      • 6.5.4.2. Saudi Arabia
      • 6.5.4.2.1. Key market trends, growth factors and opportunities
      • 6.5.4.2.2. Market size and forecast, by Application
      • 6.5.4.2.3. Market size and forecast, by End User
      • 6.5.4.3. South Africa
      • 6.5.4.3.1. Key market trends, growth factors and opportunities
      • 6.5.4.3.2. Market size and forecast, by Application
      • 6.5.4.3.3. Market size and forecast, by End User
      • 6.5.4.4. Rest of LAMEA
      • 6.5.4.4.1. Key market trends, growth factors and opportunities
      • 6.5.4.4.2. Market size and forecast, by Application
      • 6.5.4.4.3. Market size and forecast, by End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top player positioning, 2021

CHAPTER 8: COMPANY PROFILES

  • 8.1. Olympus Corporation
    • 8.1.1. Company overview
    • 8.1.2. Key Executives
    • 8.1.3. Company snapshot
    • 8.1.4. Operating business segments
    • 8.1.5. Product portfolio
    • 8.1.6. Business performance
    • 8.1.7. Key strategic moves and developments
  • 8.2. Stryker Corporation
    • 8.2.1. Company overview
    • 8.2.2. Key Executives
    • 8.2.3. Company snapshot
    • 8.2.4. Operating business segments
    • 8.2.5. Product portfolio
    • 8.2.6. Business performance
    • 8.2.7. Key strategic moves and developments
  • 8.3. Pentax Medical
    • 8.3.1. Company overview
    • 8.3.2. Key Executives
    • 8.3.3. Company snapshot
    • 8.3.4. Operating business segments
    • 8.3.5. Product portfolio
  • 8.4. Fujifilm Holdings
    • 8.4.1. Company overview
    • 8.4.2. Key Executives
    • 8.4.3. Company snapshot
    • 8.4.4. Operating business segments
    • 8.4.5. Product portfolio
    • 8.4.6. Business performance
    • 8.4.7. Key strategic moves and developments
  • 8.5. Medtronic plc
    • 8.5.1. Company overview
    • 8.5.2. Key Executives
    • 8.5.3. Company snapshot
    • 8.5.4. Operating business segments
    • 8.5.5. Product portfolio
    • 8.5.6. Business performance
    • 8.5.7. Key strategic moves and developments
  • 8.6. Boston Scientific Corporation
    • 8.6.1. Company overview
    • 8.6.2. Key Executives
    • 8.6.3. Company snapshot
    • 8.6.4. Operating business segments
    • 8.6.5. Product portfolio
    • 8.6.6. Business performance
    • 8.6.7. Key strategic moves and developments
  • 8.7. Endomed Systems
    • 8.7.1. Company overview
    • 8.7.2. Key Executives
    • 8.7.3. Company snapshot
    • 8.7.4. Operating business segments
    • 8.7.5. Product portfolio
  • 8.8. Sonoscape Medical Corp.
    • 8.8.1. Company overview
    • 8.8.2. Key Executives
    • 8.8.3. Company snapshot
    • 8.8.4. Operating business segments
    • 8.8.5. Product portfolio
  • 8.9. Ambu A/S
    • 8.9.1. Company overview
    • 8.9.2. Key Executives
    • 8.9.3. Company snapshot
    • 8.9.4. Operating business segments
    • 8.9.5. Product portfolio
    • 8.9.6. Business performance
    • 8.9.7. Key strategic moves and developments
  • 8.10. Endofresh
    • 8.10.1. Company overview
    • 8.10.2. Key Executives
    • 8.10.3. Company snapshot
    • 8.10.4. Operating business segments
    • 8.10.5. Product portfolio
    • 8.10.6. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 02. COLONOSCOPE MARKET FOR COLORECTAL CANCER, BY REGION, 2021-2031 ($MILLION)
  • TABLE 03. COLONOSCOPE MARKET FOR ULCERATIVE COLITIS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 04. COLONOSCOPE MARKET FOR CROHNS DISEASE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 05. COLONOSCOPE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 06. GLOBAL COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 07. COLONOSCOPE MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 08. COLONOSCOPE MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 09. COLONOSCOPE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. COLONOSCOPE MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 11. NORTH AMERICA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 12. NORTH AMERICA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 13. NORTH AMERICA COLONOSCOPE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 14. U.S. COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 15. U.S. COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 16. CANADA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 17. CANADA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 18. MEXICO COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 19. MEXICO COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 20. EUROPE COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 21. EUROPE COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 22. EUROPE COLONOSCOPE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 23. GERMANY COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 24. GERMANY COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 25. FRANCE COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 26. FRANCE COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 27. UK COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 28. UK COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 29. ITALY COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 30. ITALY COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 31. SPAIN COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 32. SPAIN COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 33. REST OF EUROPE COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 34. REST OF EUROPE COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 35. ASIA-PACIFIC COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 36. ASIA-PACIFIC COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 37. ASIA-PACIFIC COLONOSCOPE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 38. CHINA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 39. CHINA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 40. JAPAN COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 41. JAPAN COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 42. INDIA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 43. INDIA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 44. AUSTRALIA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 45. AUSTRALIA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 46. SOUTH KOREA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 47. SOUTH KOREA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 48. REST OF ASIA-PACIFIC COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 49. REST OF ASIA-PACIFIC COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 50. LAMEA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 51. LAMEA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 52. LAMEA COLONOSCOPE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 53. BRAZIL COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 54. BRAZIL COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 55. SAUDI ARABIA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 56. SAUDI ARABIA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 57. SOUTH AFRICA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 58. SOUTH AFRICA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 59. REST OF LAMEA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 60. REST OF LAMEA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 61. OLYMPUS CORPORATION: KEY EXECUTIVES
  • TABLE 62. OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • TABLE 63. OLYMPUS CORPORATION: PRODUCT SEGMENTS
  • TABLE 64. OLYMPUS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 65. OLYMPUS CORPORATION: KEY STRATERGIES
  • TABLE 66. STRYKER CORPORATION: KEY EXECUTIVES
  • TABLE 67. STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 68. STRYKER CORPORATION: PRODUCT SEGMENTS
  • TABLE 69. STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 70. STRYKER CORPORATION: KEY STRATERGIES
  • TABLE 71. PENTAX MEDICAL: KEY EXECUTIVES
  • TABLE 72. PENTAX MEDICAL: COMPANY SNAPSHOT
  • TABLE 73. PENTAX MEDICAL: SERVICE SEGMENTS
  • TABLE 74. PENTAX MEDICAL: PRODUCT PORTFOLIO
  • TABLE 75. FUJIFILM HOLDINGS: KEY EXECUTIVES
  • TABLE 76. FUJIFILM HOLDINGS: COMPANY SNAPSHOT
  • TABLE 77. FUJIFILM HOLDINGS: SERVICE SEGMENTS
  • TABLE 78. FUJIFILM HOLDINGS: PRODUCT PORTFOLIO
  • TABLE 79. FUJIFILM HOLDINGS: KEY STRATERGIES
  • TABLE 80. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 81. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 82. MEDTRONIC PLC: PRODUCT SEGMENTS
  • TABLE 83. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 84. MEDTRONIC PLC: KEY STRATERGIES
  • TABLE 85. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 86. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 87. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
  • TABLE 88. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 89. BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
  • TABLE 90. ENDOMED SYSTEMS: KEY EXECUTIVES
  • TABLE 91. ENDOMED SYSTEMS: COMPANY SNAPSHOT
  • TABLE 92. ENDOMED SYSTEMS: PRODUCT SEGMENTS
  • TABLE 93. ENDOMED SYSTEMS: PRODUCT PORTFOLIO
  • TABLE 94. SONOSCAPE MEDICAL CORP.: KEY EXECUTIVES
  • TABLE 95. SONOSCAPE MEDICAL CORP.: COMPANY SNAPSHOT
  • TABLE 96. SONOSCAPE MEDICAL CORP.: SERVICE SEGMENTS
  • TABLE 97. SONOSCAPE MEDICAL CORP.: PRODUCT PORTFOLIO
  • TABLE 98. AMBU A/S: KEY EXECUTIVES
  • TABLE 99. AMBU A/S: COMPANY SNAPSHOT
  • TABLE 100. AMBU A/S: PRODUCT SEGMENTS
  • TABLE 101. AMBU A/S: PRODUCT PORTFOLIO
  • TABLE 102. AMBU A/S: KEY STRATERGIES
  • TABLE 103. ENDOFRESH: KEY EXECUTIVES
  • TABLE 104. ENDOFRESH: COMPANY SNAPSHOT
  • TABLE 105. ENDOFRESH: PRODUCT SEGMENTS
  • TABLE 106. ENDOFRESH: SERVICE SEGMENTS
  • TABLE 107. ENDOFRESH: PRODUCT PORTFOLIO
  • TABLE 108. ENDOFRESH: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. COLONOSCOPE MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF COLONOSCOPE MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN COLONOSCOPE MARKET (2022-2031)
  • FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 06. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALCOLONOSCOPE MARKET
  • FIGURE 10. COLONOSCOPE MARKET, BY APPLICATION, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF COLONOSCOPE MARKET FOR COLORECTAL CANCER, BY COUNTRY 2021-2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF COLONOSCOPE MARKET FOR ULCERATIVE COLITIS, BY COUNTRY 2021-2031(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF COLONOSCOPE MARKET FOR CROHNS DISEASE, BY COUNTRY 2021-2031(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF COLONOSCOPE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 15. COLONOSCOPE MARKET, BY END USER, 2021(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF COLONOSCOPE MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF COLONOSCOPE MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY 2021-2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF COLONOSCOPE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 19. COLONOSCOPE MARKET BY REGION, 2021
  • FIGURE 20. U.S. COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 21. CANADA COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 22. MEXICO COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 23. GERMANY COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 24. FRANCE COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 25. UK COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 26. ITALY COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 27. SPAIN COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. REST OF EUROPE COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. CHINA COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. JAPAN COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. INDIA COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. AUSTRALIA COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. SOUTH KOREA COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. REST OF ASIA-PACIFIC COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. BRAZIL COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. SAUDI ARABIA COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. SOUTH AFRICA COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. REST OF LAMEA COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 42. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 43. COMPETITIVE DASHBOARD
  • FIGURE 44. COMPETITIVE HEATMAP: COLONOSCOPE MARKET
  • FIGURE 45. TOP PLAYER POSITIONING, 2021
  • FIGURE 46. OLYMPUS CORPORATION: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 47. OLYMPUS CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 48. OLYMPUS CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 49. STRYKER CORPORATION: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 50. STRYKER CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 51. STRYKER CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 52. FUJIFILM HOLDINGS: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 53. FUJIFILM HOLDINGS: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 54. FUJIFILM HOLDINGS: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 55. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 57. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 58. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 59. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 60. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 61. AMBU A/S: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 62. AMBU A/S: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 63. AMBU A/S: REVENUE SHARE BY REGION, 2022 (%)